Speaker illustration

Ms Linda Joosten

Julius Center for Health Sciences and Primary Care, Utrecht (Netherlands (The))

Linda Joosten obtained her medical degree in 2016. In 2017, she started her PhD trajectory at the Julius Center for Health Sciences and Primary Care of the University Medical Center Utrecht, Utrecht University, under the supervision of dr. Geert-Jan Geersing, dr. Sander van Doorn, prof. dr. Frans Rutten and prof. dr. Arno Hoes. Her research is about management of patients with atrial fibrillation (AF) in the community. Within this area of interest, she focuses on the FRAIL-AF multicenter randomized controlled trial in which she evaluates whether the impact of a strategy aimed at switching INR-guided VKA-management to a NOAC-based treatment strategy is superior in terms of the occurrence of major or clinically relevant non-major bleeding complications in frail elderly patients with AF. In 2021, she finished the Postgraduate Master of Epidemiology at Utrecht University. She is expected to complete her training in General Practice in November 2023 and her PhD trajectory in 2024.

Ask the Trialist - FRAIL-AF

Event: ESC Congress 2023

Topic: Oral Anticoagulation

Session: Ask the Trialists from Hot Lines 6 and 7

Thumbnail

The FRAIL-AF randomized controlled trial

Event: ESC Congress 2023

Topic: Oral Anticoagulation

Session: HOT LINE 6

Thumbnail

Design of the FRAIL-AF study: safety of switching anticoagulant management (from VKA to NOAC) in frail elderly patients with atrial fibrillation: a randomised controlled trial

Event: EuroPrevent 2018

Topic: Atrial Fibrillation, Other

Session: Arrhythmias and device therapy

Thumbnail